This study is looking at whether breathing exercises, called inspiratory muscle training (IMT), can help women with early-stage breast cancer who are receiving chemotherapy. Chemotherapy can sometimes cause muscle weakness, including in the breathing muscles, leading to shortness of breath and lower activity levels. IMT uses a small handheld device to make breathing in a little harder, which may strengthen these muscles. The study aims to see if IMT improves breathing muscle strength, reduces shortness of breath, and increases physical activity. You may be able to join if you are an adult woman, starting chemotherapy for early-stage breast cancer within 3 weeks, can exercise independently, and can read and understand English. The main goal is to measure changes in your maximum inspiratory pressure (how strongly you can breathe in) over 8 weeks. The current status of this study is unclear.

Study design

This interventional study plans to enroll 58 women. Participants will be randomly assigned to one of two groups: low-intensity IMT or high-intensity IMT.

What's involved

Participants will complete three sets of fifteen repetitions of IMT per session, for 15-20 minutes, four days a week for 8 weeks.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured from baseline to 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.